Description
A Diabetes Autoantibody Panel is a blood test that detects autoantibodies—proteins produced by the immune system that mistakenly attack the body’s own insulin-producing cells in the pancreas. This panel is primarily used to help diagnose type 1 diabetes, predict the risk of developing it, and distinguish it from other forms of diabetes.
Purpose of the Test:
- Diagnose Type 1 Diabetes: Confirms autoimmune destruction of pancreatic beta cells.
- Predict Risk: Identifies individuals at higher risk for developing type 1 diabetes, including children and relatives of patients with type 1 diabetes.
- Guide Treatment: Helps clinicians determine whether insulin therapy or other management strategies are appropriate.
Typical Autoantibodies Included:
- GAD65 (Glutamic Acid Decarboxylase Antibody):
- Most common autoantibody in type 1 diabetes.
- IA-2 (Islet Antigen-2 Antibody):
- Often found in people with recent-onset type 1 diabetes.
- Insulin Autoantibody (IAA):
- Detects antibodies against insulin, typically in children.
- Zinc Transporter 8 Antibody (ZnT8):
- Helps identify autoimmune activity in the pancreas.
When This Test Is Ordered:
- If a patient presents with high blood sugar or diabetic symptoms but the type of diabetes is unclear.
- For children or adults with a family history of type 1 diabetes.
- To monitor autoimmune activity in patients with a recent diagnosis of type 1 diabetes.
What Abnormal Results Mean:
- Positive Autoantibodies: Suggest autoimmune destruction of pancreatic beta cells and indicate type 1 diabetes or increased risk.
- Negative Autoantibodies: More consistent with type 2 diabetes, MODY (maturity-onset diabetes of the young), or other forms of non-autoimmune diabetes.
Preparation:
- Fasting not required.
- Blood is drawn via venipuncture.
